Cardiovascular Systems, Inc. is a medical device company that develops and commercializes innovative atherectomy systems for treating peripheral and coronary artery disease. The company's signature Diamondback 360 system is a minimally invasive catheter-based device that removes plaque buildup from arteries to restore blood flow. CSI is now a wholly owned subsidiary of Abbott as of April 2023.